US biotech company Debut has raised USD 34 million in Series B a funding round led by BOLD, L’Oréal’s corporate venture capital fund. Additional participating investors include Fine Structure Ventures, Material Impact, GS Futures, Cavallo Ventures, Cultivian Sandbox Ventures, ACVC Partners, and others.
Cell-free model
The minority investment builds on existing joint development programs between L’Oréal and Debut that leverage the start-up’s extensive IP portfolio, from which more than 7,000.
Cell-free advanced biomanufacturing innovator receives investment in industry-exclusive agreement Clichy, 1 June 2023- BOLD, L Oréal s corporate venture. | June 1, 2023